{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:07:29Z","timestamp":1776082049594,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1023\/b:caco.0000007967.25865.29","type":"journal-article","created":{"date-parts":[[2003,12,13]],"date-time":"2003-12-13T13:10:55Z","timestamp":1071321055000},"page":"933-943","source":"Crossref","is-referenced-by-count":18,"title":["Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women"],"prefix":"10.1007","volume":"14","author":[{"given":"Sandra A.","family":"Norman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse A.","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita L.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet R.","family":"Daling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda K.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polly A.","family":"Marchbanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda F.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Liff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald T.","family":"Burkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen E.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne G.","family":"Folger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Deapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis A.","family":"Wingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Spirtas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5147145_CR1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53, 297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet\n347: 1713-1727.","journal-title":"Lancet"},{"key":"5147145_CR2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108, 411 women without breast cancer. Lancet\n350: 1047-1059.","journal-title":"Lancet"},{"key":"5147145_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"R Ross","year":"2000","unstructured":"Ross R,Paganini-Hill A,Wan P,Pike M (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progesterone. J Natl Cancer Inst\n92: 323-332.","journal-title":"J Natl Cancer Inst"},{"key":"5147145_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1008909128110","volume":"10","author":"I Persson","year":"1999","unstructured":"Persson I,Weiderpass E,Bergkvist L,Bergstrom R,Schairer C (1999) Risk of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control\n10: 253-260.","journal-title":"Cancer Causes Control"},{"key":"5147145_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","volume":"81","author":"C Magnusson","year":"1999","unstructured":"Magnusson C,Baron J,Correia N,Bergstrom R,Adami H,Persson I (1999) Breast cancer risk following long-term oestrogen and oestrogen-progestin replacement therapy. Int J Cancer\n81: 339-344.","journal-title":"Int J Cancer"},{"key":"5147145_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","volume":"283","author":"C Schairer","year":"2000","unstructured":"Schairer C,Lubin J,Troisi R,Sturgeon S,Brinton L,Hoover R (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA\n283: 485-491.","journal-title":"JAMA"},{"key":"5147145_CR7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","volume":"152","author":"G Colditz","year":"2000","unstructured":"Colditz G,Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol\n152: 950-964.","journal-title":"Am J Epidemiol"},{"key":"5147145_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","volume":"288","author":"S Hulley","year":"2002","unstructured":"Hulley S,Furnberg C,Barrett-Conner E, et al. (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen\/Progestin Replacement Study Follow-up (HERS II). JAMA\n288: 58-66.","journal-title":"JAMA"},{"key":"5147145_CR9","first-page":"593","volume":"11","author":"PA Newcomb","year":"2002","unstructured":"Newcomb PA,Titus-Ernstoff L,Egan KM, et al. (2002) Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomar\n11: 593-600.","journal-title":"Cancer Epidemiol Biomar"},{"key":"5147145_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA\n288: 321-333.","journal-title":"JAMA"},{"key":"5147145_CR11","first-page":"145","volume":"5","author":"LA Brinton","year":"1998","unstructured":"Brinton LA,Brogan DR,Coates R,Swanson C,Potischman N,Stanford JL (1998) Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause\n5: 145-151.","journal-title":"Menopause"},{"key":"5147145_CR12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U","volume":"64","author":"PK Mills","year":"1989","unstructured":"Mills PK,Beeson WL,Phillips RL,Fraser G (1989) Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer\n64: 591-597.","journal-title":"Cancer"},{"key":"5147145_CR13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00052181","volume":"6","author":"AG Schuurman","year":"1995","unstructured":"Schuurman AG,van den Brandt P,Goldbohm RA (1995) Exogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study. Cancer Causes Control\n6: 416-424.","journal-title":"Cancer Causes Control"},{"key":"5147145_CR14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/bjc.1989.288","volume":"60","author":"JL Stanford","year":"1989","unstructured":"Stanford JL,Brinton LA,Hoover RN (1989) Oral contraceptives and breast cancer: results from an expanded case-control study. Br J Cancer\n60: 375-381.","journal-title":"Br J Cancer"},{"key":"5147145_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.1995.03530020055032","volume":"274","author":"JL Stanford","year":"1995","unstructured":"Stanford JL,Weiss NS,Voigt LF,Daling JR,Habel LA,Rossing MA (1995) Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA\n274: 137-142.","journal-title":"JAMA"},{"key":"5147145_CR16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1200\/JCO.2002.20.3.699","volume":"20","author":"G Ursin","year":"2002","unstructured":"Ursin G,Tseng C-C,Paganini-Hill A, et al. (2002) Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer. J Clin Oncol\n20: 699-706.","journal-title":"J Clin Oncol"},{"key":"5147145_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","volume":"344","author":"M Clemons","year":"2001","unstructured":"Clemons M,Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med\n344: 276-285.","journal-title":"N Engl J Med"},{"key":"5147145_CR18","volume-title":"Oral Contraceptives and Breast Cancer","author":"Committee on the Relationship Between Oral ContraceptivesBreast Cancer","year":"1991","unstructured":"Committee on the Relationship Between Oral Contraceptives and Breast Cancer (1991) Oral Contraceptives and Breast Cancer. Washington, D.C.: National Academy Press."},{"key":"5147145_CR19","first-page":"4559","volume":"84","author":"L Hofseth","year":"1999","unstructured":"Hofseth L,Raafat A,Osuch J,Pathak D,Slomski C,Haslam S (1999) Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal post-menopausal breast. J Clin Endocrinol Metab\n84: 4559-4565.","journal-title":"J Clin Endocrinol Metab"},{"key":"5147145_CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/mob.2001.110447","volume":"184","author":"AM Raafat","year":"2001","unstructured":"Raafat AM,Hofseth LJ,Haslam SZ (2001) Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model. Am J Obstet Gynecol\n184: 340-349.","journal-title":"Am J Obstet Gynecol"},{"key":"5147145_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1097-4652(2001)9999:9999<::AID-JCP1056>3.0.CO;2-0","volume":"187","author":"AM Raafat","year":"2001","unstructured":"Raafat AM,Songjiang L,Bennett JM,Hafseth LJ,Haslam SZ (2001) Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model. J Cell Physiol\n187: 81-89.","journal-title":"J Cell Physiol"},{"key":"5147145_CR22","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","volume":"346","author":"PA Marchbanks","year":"2002","unstructured":"Marchbanks PA,McDonald JA,Wilson HG, et al. (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med\n346: 2025-2032.","journal-title":"N Engl J Med"},{"key":"5147145_CR23","first-page":"1148","volume":"100","author":"LK Weiss","year":"2002","unstructured":"Weiss LK,Burkman RT,Cushing-Haugen K, et al. (2002) Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol\n100: 1148-1158.","journal-title":"Obstet Gynecol"},{"key":"5147145_CR24","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.10984","volume":"95","author":"JR Daling","year":"2002","unstructured":"Daling JR,Malone KE,Doody DR, et al. (2002) Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer\n95: 2455-2464.","journal-title":"Cancer"},{"key":"5147145_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1047-2797(01)00274-5","volume":"12","author":"PA Marchbanks","year":"2002","unstructured":"Marchbanks PA,McDonald JA,Wilson HG, et al. (2002) The NICHD Women's Contraceptive and Reproductive Experiences Study: Methods and Operational Results. Ann Epidemiol\n12: 213-221.","journal-title":"Ann Epidemiol"},{"key":"5147145_CR26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a114942","volume":"128","author":"PA Wingo","year":"1998","unstructured":"Wingo PA,Ory HW,Layde PM, et al. (1998) The evaluation of the data collection process for a multicenter, population-based case-control design. Am J Epidemiol\n128: 206-217.","journal-title":"Am J Epidemiol"},{"key":"5147145_CR27","volume-title":"Pharmacoepidemiology","author":"S West","year":"2000","unstructured":"West S,Strom B (2000) Validity of Pharmacoepidemiology Drug and Diagnosis Data. In: Strom B, ed. Pharmacoepidemiology, 3rd ed. Sussex: John Wiley.","edition":"3rd ed."},{"key":"5147145_CR28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/oxfordjournals.aje.a009515","volume":"147","author":"MC Pike","year":"1998","unstructured":"Pike MC,Ross RK,Spicer DV (1998) Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol\n147: 718-721.","journal-title":"Am J Epidemiol"},{"key":"5147145_CR29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/oxfordjournals.aje.a010220","volume":"151","author":"B Rockhill","year":"2000","unstructured":"Rockhill B,Colditz GA,Rosner B (2000) Bias in breast cancer analyses due to error in age at menopause. Am J Epidemiol\n151: 404-408.","journal-title":"Am J Epidemiol"},{"key":"5147145_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/oxfordjournals.epirev.a036119","volume":"15","author":"KE Malone","year":"1993","unstructured":"Malone KE,Daling JR,Weiss NS (1993) Oral contraceptives in relation to breast cancer. Epidemiol Rev\n15: 80-97.","journal-title":"Epidemiol Rev"},{"key":"5147145_CR31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-137-10-200211190-00013","volume":"137","author":"U.S. Preventive Services Task Force","year":"2002","unstructured":"U.S. Preventive Services Task Force (2002) Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med\n137: 834-839.","journal-title":"Ann Intern Med"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000007967.25865.29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:CACO.0000007967.25865.29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000007967.25865.29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:38:58Z","timestamp":1750963138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:CACO.0000007967.25865.29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["5147145"],"URL":"https:\/\/doi.org\/10.1023\/b:caco.0000007967.25865.29","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}